Medications for Colorectal Cancer
Other names: Cancer, Colon; Cancer, Colorectal; Cancer, Rectal; Colon Cancer; Colon Carcinoma; Colorectal Carcinoma; Rectal Cancer
About Colorectal Cancer: The colon and rectum are part of the large intestine (large bowel). Colon and rectum cancers, which are sometimes referred to together as "colorectal cancer," arise from the lining of the large intestine. (When cancer arises from the lining of an organ like the large intestine, it is called a carcinoma.)
Other types of colon cancer are rare, and include lymphoma, carcinoid tumors, melanoma, and sarcomas. Use of the term "colon cancer" for the rest of this article refers to colon "carcinoma" and not the other, rare types of colon cancer.
See also: sub-topics
Drugs Used to Treat Colorectal Cancer
The following list of medications are in some way related to, or used in the treatment of this condition.
Topics under Colorectal Cancer
- Anal Cancer (4 drugs)
- Familial Adenomatous Polyposis (4 drugs)
Learn more about Colorectal Cancer
IBM Watson Micromedex
Symptoms and treatments
Drugs.com Health Center
Mayo Clinic Reference
Legend
| Rx | Prescription Only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Off Label | This medication may not be approved by the FDA for the treatment of this condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
| N | FDA has not classified the drug. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| 1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
| 2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
| 3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
